The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.72BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Trailing P/E
22.72x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Revenue (TTM)
6.41BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Profit Margin
1.22%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Beta
0.7170x
vs all stocks
Updated Oct 26, 2026
52-Week Change
-19.55%
vs all stocks
Updated Oct 26, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Market Capitalization
1.72BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Enterprise Value
3.66BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Trailing P/E
22.72x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Forward P/E
9.78x
vs Medical Care Facilities peers
Updated Oct 26, 2026
PEG Ratio
-0.2954x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Price to Sales (TTM)
0.2702x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Price to Book (MRQ)
1.29x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Enterprise to Revenue
0.5720x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Enterprise to EBITDA
8.67x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Gross Margin
41.08%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 58.38%.Updated Oct 26, 2026
Profit Margin
1.22%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Operating Margin
3.44%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Return on Assets (TTM)
3.13%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Return on Equity (TTM)
9.96%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Revenue (TTM)
6.41BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Revenue per Share (TTM)
45.31USDUpdated Oct 26, 2026
Quarterly Revenue Growth
-1.40%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Gross Profit (TTM)
3.74BUSD
vs all stocks (USD)
Updated Oct 26, 2026
EBITDA (TTM)
430.90MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Net Income (TTM)
78.23MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Quarterly Earnings Growth (YoY)
-76.80%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Operating Cash Flow (TTM)
514.32MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Levered Free Cash Flow (TTM)
208.31MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 26, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 26, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Oct 26, 2026
Minority Interest (Equity)
397.07MUSDFY2025 · Dec 31, 2025
Revenue
6.32BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
3.74BUSDFY2025 · Dec 31, 2025
Gross Profit
2.58BUSDFY2025 · Dec 31, 2025
Operating Income
325.58MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
286.36MUSDFY2025 · Dec 31, 2025
Income Tax Expense
56.22MUSDFY2025 · Dec 31, 2025
Net Income
230.13MUSDFY2025 · Dec 31, 2025
EBIT
341.56MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
504.61MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
1.46BUSDFY2025 · Dec 31, 2025
Other Operating Expenses
647.31MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
55.20MUSDFY2025 · Dec 31, 2025
EPS (Basic)
0.9600USDFY2025 · Dec 31, 2025
EPS (Diluted)
0.9600USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
140.76MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
140.76MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
230.13MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
-94.32MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
592.45MUSDFY2025 · Dec 31, 2025
Free Cash Flow
380.54MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
709.60MUSDFY2025 · Dec 31, 2025
Income Tax Paid
36.51MUSDFY2025 · Dec 31, 2025
Interest Paid
65.74MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
230.13MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
155.70MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
43.59MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
39.29MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
5.65MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
59.16MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
62.06MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-3.15MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-211.90MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-2.50MUSDFY2025 · Dec 31, 2025
Other Investing Activity
179.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-214.23MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-7.99MUSDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-95.48MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-103.47MUSDFY2025 · Dec 31, 2025
Shares Outstanding
141.91MSharesUpdated Oct 26, 2026
Float Shares
21.76MSharesUpdated Oct 26, 2026
Shares Short
4.63MSharesUpdated Oct 26, 2026
Short Ratio
10.62days
vs all stocks
Updated Oct 26, 2026
Short % of Shares Outstanding
14.96%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 3.26%.Updated Oct 26, 2026
% Held by Insiders
23.84%
vs all stocks
Updated Oct 26, 2026
% Held by Institutions
76.82%
vs all stocks
Updated Oct 26, 2026
Total Cash (MRQ)
724.48MUSD
vs all stocks (USD)
Updated Oct 26, 2026
Total Cash per Share (MRQ)
5.14USDUpdated Oct 26, 2026
Total Debt (MRQ)
2.27BUSD
vs all stocks (USD)
Updated Oct 26, 2026
Total Debt to Equity (MRQ)
1.30x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Current Ratio (MRQ)
2.10x
vs Medical Care Facilities peers
Updated Oct 26, 2026
Book Value per Share (MRQ)
9.52USDUpdated Oct 26, 2026
Total Assets
5.29BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.06BUSDFY2025 · Dec 31, 2025
Total Liabilities
3.61BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.23BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.56BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.05BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
709.60MUSDFY2025 · Dec 31, 2025
Accounts Receivable
686.10MUSDFY2025 · Dec 31, 2025
Inventory
118.59MUSDFY2025 · Dec 31, 2025
Accounts Payable
457.94MUSDFY2025 · Dec 31, 2025
Short-term Debt
76.94MUSDFY2025 · Dec 31, 2025
Long-term Debt
2.24BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
317.69MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
1.43MUSDFY2025 · Dec 31, 2025
Retained Earnings
501.61MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.68BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.71USDUpdated Oct 26, 2026
52-Week High
15.48USDUpdated Oct 26, 2026
52-Week Change
-19.55%
vs all stocks
Updated Oct 26, 2026
Beta
0.7170x
vs all stocks
Updated Oct 26, 2026
50-Day MA
11.04USDUpdated Oct 26, 2026
200-Day MA
9.90USDUpdated Oct 26, 2026
Avg 10-Day Volume
513.29KSharesUpdated Oct 26, 2026
Avg 30-Day Volume
468.70KSharesUpdated Oct 26, 2026
Diluted EPS (TTM)
0.5400USDUpdated Oct 26, 2026
Other Income / Expense
15.98MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.41Profit Margin: 0.01
Financial Health
Altman Z-Score 2.06: grey zoneSignificant
Altman Z-Score: 2.06
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.72B, above the global median of $1.14BNotable
Market cap (USD): 1,717,939,147Global Median: 1,137,180,293.291
Revenue is $6.41B, above the global median of $566.17MNotable